News & Updates

Faecal microbiota spores deliver benefit in older patients with C. diff recurrence

22 Dec 2023 by

In an integrated analysis of two phase III ECOSPOR trials presented at AIBD 2023, faecal microbiota spores (ie, live-brpk) demonstrated favourable safety and efficacy signals for the treatment of recurrent Clostridioides (C.) difficile infection (CDI) in older individuals.

Faecal microbiota spores deliver benefit in older patients with C. diff recurrence

22 Dec 2023

10-year study: High incidence and mortality of acquired haemophilia A in HK

22 Dec 2023 by

A retrospective, territory-wide, 10-year study has shown high incidence and mortality of acquired haemophilia A (AHA) in Hong Kong. Immunosuppression-related sepsis was the major cause of mortality, indicating the need for individualized immunosuppressive therapy (IST).

10-year study: High incidence and mortality of acquired haemophilia A in HK

22 Dec 2023

Nocturnal reflux, snoring linked to increased risk of asthma, respiratory problems

22 Dec 2023

People with nocturnal gastroesophageal reflux (GER) and habitual snoring are vulnerable to developing asthma and respiratory symptoms, according to a study.

Nocturnal reflux, snoring linked to increased risk of asthma, respiratory problems

22 Dec 2023

Risankizumab as induction therapy induces clinical remission in UC

22 Dec 2023 by

Induction therapy with risankizumab, a monoclonal antibody neutralizing interleukin-23p19, resulted in significantly higher clinical remission rates among patients with moderate-to-severe ulcerative colitis (UC) compared with placebo, according to the INSPIRE trial presented at AIBD 2023.

Risankizumab as induction therapy induces clinical remission in UC

22 Dec 2023

Acitretin plus triamcinolone treats oral lichen planus better than triamcinolone monotherapy

21 Dec 2023

The combination of oral acitretin plus topical triamcinolone acetonide (TAC) appears to have superior efficacy than TAC alone in the treatment of patients with oral lichen planus, as shown in a study.

Acitretin plus triamcinolone treats oral lichen planus better than triamcinolone monotherapy

21 Dec 2023

Abiraterone plus prednisolone, enzalutamide a toss-up in castration-resistant prostate cancer

21 Dec 2023 by

The combination of abiraterone plus prednisolone appears to have similar efficacy and safety as enzalutamide in the treatment of patients with nonmetastatic castration-resistant prostate cancer, according to a study.

Abiraterone plus prednisolone, enzalutamide a toss-up in castration-resistant prostate cancer

21 Dec 2023

Routine testing for enterovirus CNS infection a must in febrile infants: study

21 Dec 2023

Infants with human nonpolio enterovirus (EV) central nervous system (CNS) infection often present without cerebrospinal fluid (CSF) pleocytosis, reports a study.

Routine testing for enterovirus CNS infection a must in febrile infants: study

21 Dec 2023

Somapacitan safe, effective in children with growth hormone deficiency

21 Dec 2023 by

Use of somapacitan, a long-acting growth hormone (GH) derivative, for 2 years is efficacious and well tolerated in prepubertal children with GH deficiency (GHD), reports a study.

Somapacitan safe, effective in children with growth hormone deficiency

21 Dec 2023

Serum DHEA, testosterone levels inversely linked to CAC in older men

21 Dec 2023

In older men, serum levels of dehydroepiandrosterone (DHEA) and testosterone correlate inversely with coronary artery calcification (CAC), partially independently from each other, a study has shown.

Serum DHEA, testosterone levels inversely linked to CAC in older men

21 Dec 2023

Iptacopan delivers durable responses in anti-C5-treated PNH patients with anaemia

21 Dec 2023 by

The final results of the pivotal phase III APPLY-PNH trial show sustained efficacy and safety of the oral factor B inhibitor iptacopan in anti-C5-treated patients with paroxysmal nocturnal haemoglobinuria (PNH) and persistent anaemia.

Iptacopan delivers durable responses in anti-C5-treated PNH patients with anaemia

21 Dec 2023

News & Updates

Filter by Specialty:

Specialty:

Faecal microbiota spores deliver benefit in older patients with C. diff recurrence

Faecal microbiota spores deliver benefit in older patients with C. diff recurrence

10-year study: High incidence and mortality of acquired haemophilia A in HK

10-year study: High incidence and mortality of acquired haemophilia A in HK

Nocturnal reflux, snoring linked to increased risk of asthma, respiratory problems

Nocturnal reflux, snoring linked to increased risk of asthma, respiratory problems

Risankizumab as induction therapy induces clinical remission in UC

Risankizumab as induction therapy induces clinical remission in UC

Acitretin plus triamcinolone treats oral lichen planus better than triamcinolone monotherapy

Acitretin plus triamcinolone treats oral lichen planus better than triamcinolone monotherapy

Abiraterone plus prednisolone, enzalutamide a toss-up in castration-resistant prostate cancer

Abiraterone plus prednisolone, enzalutamide a toss-up in castration-resistant prostate cancer

Routine testing for enterovirus CNS infection a must in febrile infants: study

Routine testing for enterovirus CNS infection a must in febrile infants: study

Somapacitan safe, effective in children with growth hormone deficiency

Somapacitan safe, effective in children with growth hormone deficiency

Serum DHEA, testosterone levels inversely linked to CAC in older men

Serum DHEA, testosterone levels inversely linked to CAC in older men

Iptacopan delivers durable responses in anti-C5-treated PNH patients with anaemia

Iptacopan delivers durable responses in anti-C5-treated PNH patients with anaemia